294 related articles for article (PubMed ID: 36338164)
1. Substantially Elevated Atherosclerotic Risks in Japanese Severe Familial Hypercholesterolemia Defined by the International Atherosclerosis Society.
Funabashi S; Kataoka Y; Hori M; Ogura M; Nakaoku Y; Nishimura K; Doi T; Nishikawa R; Tsuda K; Noguchi T; Harada-Shiba M
JACC Asia; 2021 Sep; 1(2):245-255. PubMed ID: 36338164
[TBL] [Abstract][Full Text] [Related]
2. Low-density lipoprotein apheresis: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2007; 7(5):1-101. PubMed ID: 23074505
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness and Safety of Lipid-Lowering Drug Treatments in Japanese Patients with Familial Hypercholesterolemia: Familial Hypercholesterolemia Expert Forum (FAME) Study.
Yamashita S; Masuda D; Harada-Shiba M; Arai H; Bujo H; Ishibashi S; Daida H; Koga N; Oikawa S
J Atheroscler Thromb; 2022 May; 29(5):608-638. PubMed ID: 33980760
[TBL] [Abstract][Full Text] [Related]
4. Long-Term Risk of Atherosclerotic Cardiovascular Disease in US Adults With the Familial Hypercholesterolemia Phenotype.
Perak AM; Ning H; de Ferranti SD; Gooding HC; Wilkins JT; Lloyd-Jones DM
Circulation; 2016 Jul; 134(1):9-19. PubMed ID: 27358432
[TBL] [Abstract][Full Text] [Related]
5. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE.
Jellinger PS; Handelsman Y; Rosenblit PD; Bloomgarden ZT; Fonseca VA; Garber AJ; Grunberger G; Guerin CK; Bell DSH; Mechanick JI; Pessah-Pollack R; Wyne K; Smith D; Brinton EA; Fazio S; Davidson M
Endocr Pract; 2017 Apr; 23(Suppl 2):1-87. PubMed ID: 28437620
[TBL] [Abstract][Full Text] [Related]
6. How Can We Identify Very High-Risk Heterozygous Familial Hypercholesterolemia?
Kataoka Y; Funabashi S; Doi T; Harada-Shiba M
J Atheroscler Thromb; 2022 Jun; 29(6):795-807. PubMed ID: 35022364
[TBL] [Abstract][Full Text] [Related]
7. Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at "Extreme" ASCVD Risk.
Rosenblit PD
Curr Diab Rep; 2019 Nov; 19(12):146. PubMed ID: 31754844
[TBL] [Abstract][Full Text] [Related]
8. Coronary Artery Calcium and Cardiovascular Events in Patients With Familial Hypercholesterolemia Receiving Standard Lipid-Lowering Therapy.
Miname MH; Bittencourt MS; Moraes SR; Alves RIM; Silva PRS; Jannes CE; Pereira AC; Krieger JE; Nasir K; Santos RD
JACC Cardiovasc Imaging; 2019 Sep; 12(9):1797-1804. PubMed ID: 30448145
[TBL] [Abstract][Full Text] [Related]
9. Value of the Definition of Severe Familial Hypercholesterolemia for Stratification of Heterozygous Patients.
Pérez-Calahorra S; Sánchez-Hernández RM; Plana N; Marco-Benedi V; Pedro-Botet J; Almagro F; Brea A; Ascaso JF; Lahoz C; Civeira F;
Am J Cardiol; 2017 Mar; 119(5):742-748. PubMed ID: 28081939
[TBL] [Abstract][Full Text] [Related]
10. Impact of the severe familial hypercholesterolemia status on atherosclerotic risks.
Tada H; Nohara A; Usui S; Sakata K; Kawashiri MA; Takamura M
Sci Rep; 2023 Nov; 13(1):19782. PubMed ID: 37957199
[TBL] [Abstract][Full Text] [Related]
11. The burden of severe hypercholesterolemia and familial hypercholesterolemia in a population-based setting in the US.
Saadatagah S; Alhalabi L; Farwati M; Zordok M; Bhat A; Smith CY; Wood-Wentz CM; Bailey KR; Kullo IJ
Am J Prev Cardiol; 2022 Dec; 12():100393. PubMed ID: 36204653
[TBL] [Abstract][Full Text] [Related]
12. 2017 Taiwan lipid guidelines for high risk patients.
Li YH; Ueng KC; Jeng JS; Charng MJ; Lin TH; Chien KL; Wang CY; Chao TH; Liu PY; Su CH; Chien SC; Liou CW; Tang SC; Lee CC; Yu TY; Chen JW; Wu CC; Yeh HI;
J Formos Med Assoc; 2017 Apr; 116(4):217-248. PubMed ID: 28242176
[TBL] [Abstract][Full Text] [Related]
13. Familial Hypercholesterolemia Identification Algorithm in Patients with Acute Cardiovascular Events in A Large Hospital Electronic Database in Bulgaria: A Call for Implementation.
Petrov I; Postadzhiyan A; Vasilev D; Kasabov R; Tokmakova M; Nikolov F; Istatkov V; Zhao B; Mutafchiev D; Petkova R
Adv Ther; 2021 May; 38(5):2323-2338. PubMed ID: 33754300
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal low density lipoprotein cholesterol goal achievement and cardiovascular outcomes among adult patients with familial hypercholesterolemia: The CASCADE FH registry.
Duell PB; Gidding SS; Andersen RL; Knickelbine T; Anderson L; Gianos E; Shrader P; Kindt I; O'Brien EC; McCann D; Hemphill LC; Ahmed CD; Martin SS; Larry JA; Ahmad ZS; Kullo IJ; Underberg JA; Guyton J; Thompson P; Wilemon K; Roe MT; Rader DJ; Cuchel M; Linton MF; Shapiro MD; Moriarty PM; Knowles JW
Atherosclerosis; 2019 Oct; 289():85-93. PubMed ID: 31487564
[TBL] [Abstract][Full Text] [Related]
15. Equivalent Impact of Elevated Lipoprotein(a) and Familial Hypercholesterolemia in Patients With Atherosclerotic Cardiovascular Disease.
Hedegaard BS; Bork CS; Kaltoft M; Klausen IC; Schmidt EB; Kamstrup PR; Langsted A; Nordestgaard BG
J Am Coll Cardiol; 2022 Nov; 80(21):1998-2010. PubMed ID: 36396201
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of Diabetes and Its Association with Atherosclerotic Cardiovascular Disease Risk in Patients with Familial Hypercholesterolemia: An Analysis from the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH).
Boutari C; Rizos CV; Doumas M; Liamis G; Skoumas I; Rallidis L; Garoufi A; Kolovou G; Tziomalos K; Skalidis E; Kotsis V; Sfikas G; Lambadiari V; Anagnostis P; Bilianou E; Anastasiou G; Koutagiar I; Kiouri E; Attilakos A; Kolovou V; Zacharis E; Antza C; Liberopoulos E
Pharmaceuticals (Basel); 2022 Dec; 16(1):. PubMed ID: 36678541
[TBL] [Abstract][Full Text] [Related]
17. Long-term lipoprotein apheresis in the treatment of severe familial hypercholesterolemia refractory to high intensity statin therapy: Three year experience at a lipoprotein apheresis centre.
Mickiewicz A; Borowiec-Wolna J; Bachorski W; Gilis-Malinowska N; Gałąska R; Raczak G; Chmara M; Wasąg B; Jaguszewski MJ; Fijałkowski M; Gruchała M
Cardiol J; 2019; 26(6):669-679. PubMed ID: 30234904
[TBL] [Abstract][Full Text] [Related]
18. Relation of Serum Lipoprotein(a) Levels to Lipoprotein and Apolipoprotein Profiles and Atherosclerotic Diseases in Japanese Patients with Heterozygous Familial Hypercholesterolemia: Familial Hypercholesterolemia Expert Forum (FAME) Study.
Naito R; Daida H; Masuda D; Harada-Shiba M; Arai H; Bujo H; Ishibashi S; Koga N; Oikawa S; Yamashita S
J Atheroscler Thromb; 2022 Aug; 29(8):1188-1200. PubMed ID: 34456199
[TBL] [Abstract][Full Text] [Related]
19. Clinical Features and Gaps in the Management of Probable Familial Hypercholesterolemia and Cardiovascular Disease.
Zafrir B; Jubran A; Lavie G; Halon DA; Flugelman MY; Shapira C
Circ J; 2017 Dec; 82(1):218-223. PubMed ID: 28701632
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
